Primary antibody deficiency syndromes.

Area of Science:

• Immunology
• Genetics
• Clinical Medicine

Background:

• Primary antibody deficiency syndromes are rare disorders affecting immunoglobulin production.
• They stem from genetic mutations or polygenic factors impacting B cell development.
• Common presentations include recurrent bacterial infections and autoimmunity, particularly in Common Variable Immunodeficiency (CVID).

Purpose of the Study:

• To provide a comprehensive overview of primary antibody deficiency syndromes.
• To cover their pathogenesis, clinical presentation, laboratory diagnosis, and management.
• To highlight the importance of distinguishing these from secondary hypogammaglobulinaemia.

Main Methods:

• Literature review of primary antibody deficiency syndromes.
• Analysis of diagnostic challenges and laboratory roles.
• Overview of current therapeutic strategies and monitoring requirements.

Main Results:

• Diagnostic delay is a significant issue, emphasizing the need for accurate laboratory detection of immunoglobulin abnormalities.
• Immunoglobulin replacement therapy is the primary treatment.
• Patients face risks of complications, including lymphoid malignancy, necessitating ongoing monitoring.

Conclusions:

• Early and accurate diagnosis through laboratory investigations is critical for effective management.
• Immunoglobulin replacement therapy improves outcomes but does not eliminate all risks.
• Long-term clinical and laboratory monitoring is essential for patients with primary antibody deficiencies, especially CVID.